Serum Biotinidase Activity in Children Treated With Valproic Acid and Carbamazepine

Abstract

There is evidence that valproic acid causes a reduction of serum biotinidase enzyme activity. We determined the serum concentration of antiepileptic drugs, transaminases, γ-glutamyl transferase, ammonia, and biotinidase enzyme activity in 57 children treated with valproic acid, in 17 children treated with carbamazepine, and in 75 age- and sex-matched healthy controls. There were no significant differences in the serum biotinidase enzyme activity between the patients treated with valproic acid, the patients treated with carbamazepine, and the control group. Hyperammonemia was detected in 8 patients treated with valproic acid. Hair loss was observed in 3 female patients treated with valproic acid, and the alopecia disappeared with the oral administration of biotin (10 mg/ d) in 3 months. These results suggest that the treatment with valproic acid does not alter the serum biotinidase enzyme activity.

Keywords

ammonia biotin biotinidase carbamazepine hair loss transaminases valproic acid

Get full access to this article

View all access options for this article.

References

Wilder BJ Gastrointestinal tolerance of sodium valproate. Neurology . 1983;33(6):808-811.

McKinney PA , Finkebine RD , DeVane CI Alopecia and mood stabilizer therapy. Ann Clin Psychiatry . 1996;8(3):183-185.

Wallace SJ A comparative review of the adverse effects of anticonvulsants in children with epilepsy. Drug Saf. 1996;15(6):379-393.

Dreifuss FE Valproic acid toxicity. In: Levy RH , Mattson RH , Meldrum BS , eds. Antiepileptic Drugs. 4th ed. New Jersey: Lippinvott-Raven Healthcare; 1996:641-648.

Ohtani Y. , Endo F. , Matsuda I. Carnitine deficiency and hyperammonemia associated with valproic acid therapy . J Pediatr. 1982;101(5):782-785.

Castro-Gago M. , Novo I. , Rodríguez-Segade S. Effects of valproic acid on the urea cycle and carnitine metabolism. Int Pediatr. 1990;5(1):54-57.

Castro-Gago M. , Eirís-Punal J. , Novo-Rodríguez MI , Couceiro J. , Camina F. , Rodríguez-Segade S. Serum carnitine levels in epileptic children before and during treatment with valproic acid, carbamazepine, and phenobarbital. J Child Neurol . 1998; 13(11):546-549.

Schulpis KH , Karikas GA , Tjamouranis J. , Regoutas S. , Tsakiris S. Low serum biotinidase activity in children with valproic acid monotherapy . Epilepsia. 2001;42(10):1359-1362.

Yilmaz Y. , Tasdemir HA , Paksu MS The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity. Eur J Paediatr Neurol. 2008 [Epub ahead of print].

10.

Korkmazer N. , Vurucu S. , Demirkaya E. , et al. Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid. Brain Dev. 2006;28(8):515-520.

11.

Arslan M. , Vurucu S. , Balamtekin N. , et al. The effects of biotin supplementation on serum and liver tissue biotinidase activity and alopecia in rats which were administrated to valproic acid. Brain Dev. 2008 [Epub ahead of print].

12.

Wolf B. , Grier RE , Allen RJ , Goodman SI , Kien CL Biotinidase deficiency: enzymatic defect in late onset multiple carboxylase deficiency. Clin Chim Acta. 1983;131(3):273-281.

13.

Stanley SJ , Griffin JB , Zempleni J. Biotinylation of histones in human cells. Effects of cell proliferation. Eur J Biochem. 2001;268(20):5424-5429.

14.

Krause K. -H, Berlit P. , Bonjour J-P. Impaired biotin status in anticonvulsant therapy. Ann Neurol . 1982;12(5):485-486.

15.

Krause K. -H, Kochen W. , Berlit P. , Bonjour J-P. Excretion of organic acids associated with biotin deficiency in chronic anticonvulsant therapy. Int J Vitam Nutr Res. 1984;54(2-3):217-222.

16.

Krause K. -H, Bonjour J-P. , Berlit P. , Kochen W. Biotin status of epileptics. Ann N Y Acad Sci. 1985;447:297-313.

17.

Krause KH , Bonjour JP , Berlit P. , Kynast G. , Schmidt-Gayk H. , Schellenberg B. Effect of long-term treatment with antiepileptic drugs on the vitamin status . Drug Nutr Interact. 1988;5(4): 317-343.

18.

Hymes J. , Wolf B. Biotinidase and its roles in biotin metabolism. Clin Chim Acta. 1996;255(1):1-11.

19.

Grier RE , Heard GS , Watkins P. , Wolf B. Low biotinidase activities in the sera of patients with impaired liver function: evidence that the liver is the source of serum biotinidase. Clin Chim Acta. 1990;186(3):397-400.

20.

Anagnostouli M. , Livaniou E. , Nyalala JO , et al. Cerebrospinal fluid levels of biotin in various neurological disorders. Acta Neurol Scand. 1999;99(6):387-392.